Contrasting Solesence (NASDAQ:SLSN) and Lifevantage (NASDAQ:LFVN)

Lifevantage (NASDAQ:LFVN) and Solesence (NASDAQ:SLSN) are both small-cap consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.

Insider and Institutional Ownership

35.3% of Lifevantage shares are owned by institutional investors. Comparatively, 70.2% of Solesence shares are owned by institutional investors. 13.6% of Lifevantage shares are owned by insiders. Comparatively, 4.8% of Solesence shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current ratings for Lifevantage and Solesence, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifevantage	1	2	0	0	1.67
Solesence	1	0	0	0	1.00

Lifevantage presently has a consensus price target of $5.50, indicating a potential upside of 16.53%. Given Lifevantage’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Lifevantage is more favorable than Solesence.

Profitability

This table compares Lifevantage and Solesence’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Lifevantage	1.58%	16.34%	8.81%
Solesence	-3.40%	-11.58%	-3.79%

Volatility & Risk

Lifevantage has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500. Comparatively, Solesence has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500.

Valuation and Earnings

This table compares Lifevantage and Solesence”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifevantage	$182.59 million	0.33	$5.07 million	$0.40	11.80
Solesence	$55.37 million	1.16	$1.79 million	($0.03)	-30.37

Lifevantage has higher revenue and earnings than Solesence. Solesence is trading at a lower price-to-earnings ratio than Lifevantage, indicating that it is currently the more affordable of the two stocks.

Summary

Lifevantage beats Solesence on 10 of the 13 factors compared between the two stocks.

About Lifevantage

LifeVantage Corporation is a health and wellness company that develops, markets and distributes dietary supplements and personal-care products. Its product portfolio is designed to support areas such as cellular health, antioxidant defenses, energy, nutrition and skin care. The company’s principal brands have included Protandim, a line of dietary supplements; TrueScience, a skin-care and wellness brand; and Petandim, products formulated for pets. LifeVantage primarily uses a direct-selling business model, distributing its products through independent sales representatives and online channels.

About Solesence

Solesence is a skincare company focused on developing science-based products designed to protect, improve and maintain the health and appearance of skin. Its work centers on combining cosmetic formulations with dermatological and cosmetic science, particularly in areas such as daily skin protection and visible signs of skin aging. The company develops skincare and sun-care formulations for use in branded and private-label products. Its offerings are intended to support needs including mineral sun protection, hydration, skin tone and texture, and anti-aging care.